Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
(S)-Sunvozertinib is an inhibitor of mutant EGFR and the enantiomer of sunvozertinib (Item No. 46085).1 It selectively inhibits the phosphorylation of EGFRL858R/T790M and EGFR containing exon 20 insertion (ex20ins) mutations, including EGFR ex20ins ASV and EGFR ex20ins NPH, over wild-type EGFR (IC50s = 1, 52, 51, and 362 nM, respectively). (S)-Sunvozertinib also inhibits the proliferation of PaTu 8988t pancreatic cancer cells (IC50 = 5.6 µM).2
WARNING This product is not for human or veterinary use.
1. Sunvozertinib, a selective EGFR inhibitor for previously treated non-